Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 163-174
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.163
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.163
Figure 3 The partial least-squares-discriminant analysis score plots based on the metabolic fingerprints.
A: IBD active vs control; B: IBD remission vs control; C: IBD active vs IBD remission. Boxes: Serum samples; Circles: Urine samples; Red: IBD active; Blue: IBD remission; Black: Control; IBD: Inflammatory bowel diseases.
- Citation: Dawiskiba T, Deja S, Mulak A, Ząbek A, Jawień E, Pawełka D, Banasik M, Mastalerz-Migas A, Balcerzak W, Kaliszewski K, Skóra J, Barć P, Korta K, Pormańczuk K, Szyber P, Litarski A, Młynarz P. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol 2014; 20(1): 163-174
- URL: https://www.wjgnet.com/1007-9327/full/v20/i1/163.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i1.163